Pamidronate Disodium Injection
Product Images NDC 67457-430

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pamidronate Disodium (NDC 67457-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Image 01
Each vial contains Pamidronate Disodium 30mg for intravenous infusion. The inactive ingredients include Mannitol, Phosphoric acid to adjust pH (6.0 t0 7.0), and water for the injection. It is required to dilute before administration and discard the unused portion. It is important to note that mixing with calcium-containing infusion solutions is not recommended. Please refer to the package insert for dosage information. The storage temperature should be between 20°C to 25°C (68°F to 77°F). Made in India and Manufactured for Mylan Institutional LLC, Rockford, IL 61103 U.S.A.*
FDA Label Image

Image 02

Image 02
Each vial contains Pamidronate Disodium 90 mg suspended in Mannitol 375 mg, Phosphoric Acid to adjust pH, and Water for Injection. The solution is sterile and requires further dilution before intravenous infusion. The package insert should be consulted for the proper dosage for each indication, and unused portions should be discarded. Storage is recommended between 20°C and 25°C. This drug should not be mixed with calcium-containing infusion solutions. The product is manufactured by Mylan Institutional LLC in India.*
FDA Label Image

Structure (Pamidronate Inj Mylan Figure 01)

Structure (Pamidronate Inj Mylan Figure 01)
POHNa may refer to sodium hypophosphite, which has the chemical formula NaPO2H2. It may be used as a reducing agent and in electroless nickel plating.*
FDA Label Image

Image (Pamidronate Inj Mylan Figure 02)

Image (Pamidronate Inj Mylan Figure 02)
This text provides two variables 'renal CL' and 'Pamidronate Renal CL' that are being compared. The unit of measurement is mL/min, which is likely related to kidney function. However, there is not enough context to fully understand the purpose of the comparison or the meaning of 'Cler' mentioned alongside 'renal CL'. Therefore, without additional context, the description is limited to: "Comparing renal clearance of Pamidronate to renal clearance of an unknown substance (Cler) measured in mL/min."*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.